a new biotech drug for Crohn's disease called Remicade (infliximab)

July 2001

You'll see a new biotech drug for Crohn's disease called Remicade (infliximab)...from Schering Canada.

It's a monoclonal antibody that neutralizes the activity of tumour necrosis factor...a protein that promotes inflammation.

Remicade reduces symptoms in up to 80% of patients with moderate to severe Crohn's that's resistant to usual treatment.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

new dementia guidelines that urge earlier intervention for Alzheimer's
Antidepressants a new antidepressant called Remeron(mirtazapine)
Cardiology whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension
Cardiology whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes
Allegra-D tablets in their stool
new meningococcal vaccine called Menjugate
recent meningitis outbreaks
Women's Health new oral contraceptive called Yasmin
Infectious Diseases Prevnar, the first pneumococcal vaccine that can be used in children under 2
Infectious Diseases one dose of doxycycline after a tick bite can PREVENT Lyme disease
Hematology & Oncology men who eat moderate amounts of fatty fish have a lower risk of prostate cancer
more emphasis on preventing drug-induced liver disease
Gastroenterology a new biotech drug for Crohn's disease called Remicade (infliximab)
Gastroenterology using pilocarpine eyedrops ORALLY to treat severe dry mouth
new warning about the risk of heart attacks and stroke with ephedra or ephedrine